vatreptacog alfa (NN 1731) - Novo Nordisk
FY ′10 results (Novo Nordisk) - Feb 2, 2011 -
NN1731/ Novonordisk; P3 program expected to start in mid-2011
 
Anticipated P3 trial initiation • None
http://www.larvolonline.com/tlg/ccdb/NovonordiskFY10ResultsFeb2.pdf
 
Feb 2, 2011
 
 
d1736c62-ddef-495e-8df4-264a14dfebc0.png